Skip to main content

Table 4 ED disposition and discharge arrangements

From: Downstream consequences of diagnostic error in pediatric anaphylaxis

 

Overall (n = 211)

n(%)

ED Dx anaphylaxis

(n = 105) n(%)

ED NOT Dx anaphylaxis (n = 106)

n(%)

Odds ratio (95% CI)

P value

Action plan

 Action Plan provided

59 (28.0%)

34 (32.4%)

25 (23.6%)

N/A

0.12

 Already had action plan

5 (2.4%)

4 (3.8%)

1 (0.9%)

 No mention of action plan

147 (69.7%)

67 (63.8%)

80 (75.5%)

Allergen avoidance advice provided

45 (21.3%)

23 (21.9%)

22 (20.8%)

1.07 (0.55–2.07)

0.87

Autoinjector prescription

 Autoinjector available on discharge

124 (58.8%)

86 (81.9%)

38 (35.8%)

4.12 (2.07–8.22)

< 0.001

 Autoinjector prescribed

109 (51.7%)

76 (72.4%)

33 (31.1%)

N/A

< 0.001

 Already had autoinjector

15 (7.1%)

10 (9.5%)

5 (4.7%)

 No mention of autoinjector in notes

87 (41.2%)

19 (18.1%)

68 (64.2%)

Allergist referral

 Allergist referral made

54 (25.6%)

37 (35.2%)

17 (16.0%)

2.85 (1.48–5.49)

< 0.01

 Allergist recommended but no referral

55 (26.1%)

26 (24.8%)

29 (27.4%)

0.87 (0.47–1.62)

0.75

 Known to allergista

46 (21.8%)

33 (31.4%)

13 (12.3%)

3.28 (1.61–6.68)

< 0.001

 Mention of allergist in ED notes

126 (59.8%)

74 (70.5%)

52 (49.1%)

2.48 (1.41–4.37)

< 0.01

Observation

 Median length of stay in minutes (IQR)

N/A

265 (201.5–372)

181.5 (117–272.25)

N/A

< 0.001

 In ED > 4 h

90 (42.7%)

59 (56.2%)

31 (29.2%)

3.10 (1.76–5.48)

< 0.001

 Median time of observation post epinephrine in minutes(IQR)

314 (256–629)

216 (129–490.5)

N/A

N/A

0.01

 Observed > 4 h post epinephrine

28 (90.3%)

6 (35.3%)

17.11 (3.63–80.77)

< 0.001

ED disposition

 Discharged home

57 (27.0%)

11 (10.5%)

46 (43.4%)

N/A

< 0.001

 Short stay

132 (62.6%)

83 (79.0%)

49 (46.2%)

 Ward

20 (9.5%)

9 (8.6%)

11 (10.4%)

 ICU Transfer

2 (0.9%)

2 (1.9%)

0 (0%)

  1. aNot all patients known to an allergist were referred to see them or recommended to see the again